你即將離開本站

並前往https://smallcaps.com.au/impedimed-bis-technology-nccn-includes-oncology-guidelines-lymphoedema-assessment/

ImpediMed's BIS technology gains recognition as NCCN ...

... that cancer survivors at risk of lymphoedema undergo screening at regular intervals to identify early signs through symptom assessment, ...

確定！ 回上一頁

查詢 「regular intervals中文」的人也找了：